[18F]Fluciclovine in Post-treatment Glioblastoma ( Axumin )

Clinical trial NCT03990285 · COMPLETED

Trial details

NCT number: NCT03990285
Sponsor: Ali Nabavizadeh
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Glioma Glioblastoma Multiforme

Start date: 2019-06-12
Primary completion: 2021-11-18
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.